Shire Urges Fed. Circ. To Block Actavis' Generic Lialda
In an opening brief, Ireland-based Shire urged the appeals court to uphold a May decision in which a Florida federal judge found Actavis had treaded impermissibly on two claims of U.S. Patent Number 6,773,720, which protects a controlled-release formulation for mesalamine.
The composition patent is a key obstacle to launching a copycat...
To view the full article, register now.